10/18 Conference Notes

1st Trimester Pelvic POCUS

  • All patients who are suspected to be pregnant need a transabdominal US
  • WHY? -> RULE IN UP 
  • Trans Abd US POCUS
    • Full bladder
    • Sagittal view – scan through full anatomy (1st view – best idea of what the anatomy is going to look like)
    • Transverse view 
    • Measurements
      • M -Mode for FHR
      • CRL
    • Adnexa? Probably good practice
    • Linear probe for superficial uterus for better resolution
  • TVUS
    • Hold probe with indicator on top (thumb on top)
    • When: Unable to confirm IUP on TAUS
    • Need EMPTY Bladder
    • Probe movements: Rock/Fan only
    • Start with placing probe into introitus, look at screen and then slowly advance probe with gentle pressure
  • MUST HAVE at least a YOLK SAC to be confirmed as an IUP
  • Do not use BhCG to determine if patient needs US
    • Ectopics can have BhCG level of 0 

Pleural Effusion and Opportunistic infections

  • Evaluation
    • CXR, CT, US
      • Left lateral decubitus XR more sensitive than PA,  less fluid required
    • Pleural fluid tap
  • Lights Criteria
    • Transudative vs Exudative 
  • Treatment
    • Chest tube placement for drainage
    • Antibiotics
  • Parapneumonic effusion/Empyema
    • Higher rates of morbidity and mortality
    • Higher risk in certain pops (IVDU, alcoholics, immunosuppressed, etc)
  • Antibiotics
    • Pathogens MC – S pneumo > Anaerobes > S aureus > G- bacilli
    • Empiric Tx: Pip/Tazo + vanc (meropenem, cefepime, metronidazole if PCN allergy)
  • Incomplete Drainage?
    • Fibrinolytics via thoracostomy tube
      • Alteplase + DNAse 
  • PCP (P jiroveci) Pneumonia
    • HIV patients w. CD4 <200
    • SMX/TMP 15-20mg/kg divided into 3-4 doses daily
      • Dapsone, primaquine, atovaquone if need alternative
    • Steroids if PaO2<70 mmhg
  • MAC (M avium)
    • HIV, CD4<50
    • Macrolide, ethambutol, rifampin 
  • Histoplasmosis
    • Fungal infection endemic to central and south central USA
    • Amphotericin B preferred
    • Itraconazole alternative
  • TB
    • RIPE therapy (rifampin, INH, pyrazinamide, pyridoxine, ethambutol) 
  • Candidiasis
    • Very common in HIV w/ low CD4
    • Fluconazole best, can use itraconazole

The Analytical Evaluation of an Unwanted Outcome

  • 50 yo M w/ CP/SOA while washing dog
  • pmh HTN, HLD, hypothyroidism, TB use
  • FH: brother died of MI in 40s
  • Initial EKG w/ NSR, T wave inversion III, normal otherwise
  • 2 prior ED admissions for similar symptoms w/ negative workup
  • Trop 63, sent to Jewish via Lyft for Personal vehicle 
  • Coded at Jewish in Vfib, Cath w/ 100% LAD and RCA, stented
  • Things to think about
    • ALS vs BLS vs Lyft transfer
    • Should we have stricter rules to transfer to Jewish Cards Obs?
    • Should we call the fellow or attending on cards more often?

Pneumonia

  • Severity classification for pna – differentiates what treatments to use
  • No comorbidities = Monotherapy (Beta lactam, Doxycycline)
  • Comorbidities= Beta lactam + Doxy or Azithro / or monotherapy w/ Levaquin
  • Inpatient = IV ceftriaxone + Azithro or Doxy
  • Prev hospitalization or IV abx in last 90d?  –> Vanc or Linezolid for MRSA coverage
  • 5 days usually adequate if no comorbidities
  • 7 days if Comorbid or MRSA/Pseudomonal coverage
  • Procalcitonin essentially useless, Clinical criteria alone should be used
  • Aspiration
    • Chemical pneumonitis – no abx required
      • Severe periodontal disease present – should be treated 
    • HAP / CAP = treat

Acute Bronchitis

  • Rule out: Asthma, COPD, HF, pna
  • Usually no fevers
  • CXR indicated if tachycardic, tachypneic, rusty sputum, febrile
  • Supportive care options
    • APAP, Ibuprofen, cetirizine/diphenhydramine, codeine, dextromethorphan (best results), benzonatate, guaifenesin (best data), albuterol (if wheezing or underlying asthma/copd)
  • Educate patient on why Abx may not shorten illness, give supportive therapies, and expectations of illness/cough duration
  • Bacterial
    • Sx> 10 d
    • Fever>102F w/ purulent nasal discharge/facial pain
    • Double worsening of symptoms
  • Flu
    • Oseltamivir (Tamiflu) – within 48hrs of onset
      • Initial study – sx improvement only 16hrs earlier than placebo
      • 2023 meta analysis shows no benefit over placebo w/ primary outcome of hospitalization 
    • Who should get treated?
      • Hospitalized, immunocompromised, >2 yo or <65yo, pregnant

Research

  • Think, Do, Write
  • Research is fun, rewarding, and part of being a well rounded EM physician 
  • Many conferences that you can go to (and Department will pay your way)

Leave a Reply

Your email address will not be published. Required fields are marked *